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Doubting Nongenotoxic
Mechanisms of Renal Cancer:
Comparing Apples and
Oranges in the a2u-Globulin
Hypothesis
Doubting accepted mechanisms in biology
is not wrong per se, especially as the con-
trary would be the death blow to any form
of advancement in research; however,
doubting without good reason will con-
sume precious energy and resources that
could be spent on more fruitful and cer-
tainly more pressing matters in biological
research.
Contrary to good judgment, it appears
that some individuals believe that any bio-
logical mechanism, however meticulously
established and proven with hard data and
despite being commonly accepted, should
be doubted when the mechanism in ques-
tion tends to reduce the conception ofrisk
associated with chemicals. This doubt,
however, does not appear to stem from
hard factual data contradicting the mecha-
nism, but rather from misinterpretation of
available data and, in some instances, from
the misquotation of the original investiga-
tors' conclusions.
One recent example for doubting estab-
lished and meticulously proven biological
mechanisms is the ongoing discussion of
the validity of the cc2u-globulin-associated
male rat-specific mechanism ofrenal cancer
induction and its ramifications for human
health risk assessment. A unique database
(certainly in its size and detail when com-
pared to other databases with similar
importance for human health concerns) on
practically all aspects ofthis mechanism has
been established by numerous scientists
from many different unaffiliated laborato-
ries, repeated scientific discussion sessions,
several thorough reviews (1-8), and a
workshop specifically devised to query all
aspects ofthe data that support the mecha-
nism in question (9). Despite this, some
scientists, in an unfathomable quest to dif-
fer, choose to ignore the obvious and con-
tinue to doubt the validity of this mecha-
nism by throwing up new hypotheses (10)
or interpretations of the present data (11).
Such maneuvering is all the more reproach-
able as it is not constructive to risk assess-
ment; it does not help to further the under-
standing of the currently accepted mecha-
nisms; and foremost, the authors of such
devil's-advocate papers have never present-
ed new experimental data to support any of
their new insights. In an effort to critically
address some of the alternative hypotheses
and interpretations presented by James
Huff (11) in relation to the ax2u-globulin
mechanism, John Ashby, in a letter in
Environmental Health Perspectives (12),
asked Huffto relent from generalized state-
ments and to "identify the chemicals to
which he referred and present the relevant
data for them in a focused paper."
Huff, in a reply in the same issue of
EHP, rose to the occasion and tried to
cement some ofhis statements and interpre-
tations by specifically naming the chemicals
(13). I feel that I must reply to the state-
ments made by Huff in his letter. In order
to facilitate the understanding ofthe follow-
ing paragraphs, it is necessary for the reader
to have insight into the current hypothesis
of the etiology of ca2u-globulin nephropa-
thy and associated male rat renal tumors as
well as the supporting mechanistic data.
Briefly, male rats as well as female rats,
but not mice, hamsters, guinea pigs, rab-
bits, dogs, nonhuman primates, or humans
synthesize low molecular weight proteins
(approximately 18,000-20,000 daltons)
called a2u-globulins (also known as A2u
in earlier days). Synthesis of ac2u-globulin
is reported for female and male rats in the
salivary, lachrymal, preputial, meiobian,
and perianal glands (14,15). The hormon-
al regulation of a2u-globulin synthesis in
each of these tissues is unique and, most
importantly, not sex specific in the lachry-
mal, salivary, and preputial glands
(15,16). These a2u-globulin isoforms are
electrophoretically distinct from the major
urinary protein, namely the hepatic form
of a2u-globulin with a molecular weight
of 18,700 daltons, which is exclusively syn-
thesized by male rats. The a2u-globulin
forms synthesized in small amounts by
female rats are also excreted via the urine.
However, these forms of a2u-globulin
show distinct differences to the male rat
forms of a2u-globulin, whether of non-
hepatic or hepatic origin, suggesting that
they are encoded by different genes (17).
The synthesis and high rate ofexcretion
of the hepatic form of ax2u-globulin, the
affinity of some chemicals and/or their
metabolites for binding to ax2u-globulin,
and the reduced enzymatic breakdown of
the chemical-a2u-globulin complex in
lysosomes ofthe proximal tubule epithelial
cells (18) lead to an accumulation ofthese
protein-chemical complexes in the renal
cortex ofmale rats. Subchronic and chronic
administration of chemicals was demon-
strated to be mandatory for the develop-
ment of nephrotoxicity and the formation
of renal epithelial cell tumors in male rats
(2-5). The renal tumors were demonstrat-
ed to evolve from a constantly elevated rate
ofproximal tubule epithelial cell prolifera-
tion resulting from the chemical-a2u-glob-
ulin complex-induced cell necrosis and sub-
sequent cell regeneration (19-21). Due to
the species- and sex-specific synthesis of
this low molecular weight protein,
nephropathy and kidney tumors are found
in exposed male rats but not in female rats,
a2u-globulin-deficient NBR male rats
(21,22), either sex of mice, guinea pigs,
rabbits, dogs, or nonhuman primates (1).
Although humans and other species synthe-
size and excrete low molecular weight pro-
teins via the urine, no interactions ofthese
proteins with chemicals, shown to induce
protein-mediated nephrotoxicity in the
male rat, are observed (23,24). As a result
ofa joint effort ofbasic research conducted
in both academic and industrial laborato-
ries, the nongenotoxic mechanism underly-
ing the genesis of these male rat-specific
renal epithelial tumors is among the best
characterized to date. Based on a 2-year
review of this data set, the EPA ruled that
the renal tumors detected in male rats fol-
lowing 2-year administration of nongeno-
toxic nephropathy-inducing compounds,
such as unleaded gasoline or the orange
juice component d-limonene, are of little
relevance for human cancer riskassessment.
The EPA ruling on the a2u-globulin-
mechanism and the associated simplifica-
tions and better understanding of at least
one small part of the otherwise highly
enigmatic processes involved in the etiolo-
gy of cancer has apparently driven James
Huffto question the mechanism described
above by providing examples of so-called
exceptions and discrepancies to the
presently accepted mechanism as well as to
make unfounded and scientifically
unsound statements. For example, to show
the weakness of the a2u-globulin mecha-
nism hypothesis when it comes to extrapo-
lating to the human situation, Huff states
the following:
Importantly, two additional chemicals pre-
sumed to involve [ax2u]-kidney tumors (and
thus are regarded by some as irrelevant to
humans) have nowbeen shown to beassociat-
ed with kidney cancers in humans: gasoline
[(25,26)] andtrichloroethylene [(27,28)].
The studies on gasoline that Huff cited
in the above context are epidemiological
studies. This type ofstudy looks at statistical
associations between the increased occur-
rence ofa disease and the exposure to gaso-
line (leaded gasoline). The weakness ofsuch
studies is that causal relationships and mech-
anisms can rarely be established as would be
possible in highly specific animal studies,
whereas their advantage lies in the fact that
the endpoint ofinterest, tumors in humans,
is inspecteddirectly. However, the mere asso-
ciation ofchemical exposure with increased
occurrence of disease does not prove that
there is a biological relationship. Most ofthe
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epidemiological studies performed on gaso-
line and the occurrence ofhuman renal can-
cer have an additional important weakness in
that they have not quantitatively assessed the
actual exposure to volatile hydrocarbons. In
addition, the studies were conducted with ref-
erence to leaded gasoline, thus adding the
confounding factor oflead exposure, which is
known to induce renal cancer in animal stud-
ies. Furthermore, in many studies, exposure
assessment did not go beyond ascertaining
that an individual had been employed by a
petroleum company or in a refinery. Two of
the studies (25,29) indicate asmall increase in
relative risk for kidney cancer in subgroups
exposed to gasoline. However, in the studies
by McLaughlin and co-workers (29,30) the
most consistent association with renal cancer
was found to be cigarette smoking, while in a
subsequent more detailed analysis (31), no
overall association was observed between
renal cell cancer and employment in a range
of occupations with potential exposure to
petroleum products.
Siemiatycki et al. (25), a study specifi-
cally cited by Huff, looked at the risk for
renal cancer in persons exposed to gasoline
as well as jet fuel. No statistically significant
risk for renal cancer was found for gasoline.
The only study reporting an elevated risk
and an exposure-response relationship
between kidney cancer and exposure to gaso-
line is the one published recentlyby Partanen
et al. (26). These authors reviewed 672 cases
of renal cell adenoma for a case-control
study. Owing to poor participation, only 338
sets of cases and controls were ultimately
included for analysis, thereby limiting the
interpretability of the findings. Lifelong job
histories were collected and translated into
indicators of industry, occupation, and esti-
mated occupational exposure. An elevated
risk for kidney cancer was found to be associ-
ated with a history ofwhite-collar occupa-
tions; the printing industry; the chemical
industry; the manufacture ofmetal products;
mail, telephone, and telegraph services; and
iron and metal work. An elevated risk was
associated with exposure to gasoline, and an
exposure-response relationship was observed
for increasing exposure to gasoline. However,
a major confounding factor in this risk esti-
mation was that the gasoline used in Finland,
especially during the time relevant for expo-
sure of the study group (1920-1968), con-
tained copious amounts of tetraethyl-lead.
The exposure to lead was associated with an
increased risk for renal epithelial cell cancer,
as was also confirmed by animal studies with
lead acetate (32).
The association of renal cancer in
humans with exposure to gasoline is most
likely related to the tetraethyl-lead content of
the gasoline and not to the gasoline (volatile
hydrocarbons) itself, as was also clearly point-
ed out by Partanen et al. (26). Therefore,
the statement by Huff, that "gasoline had
been shown to be associated with kidney
cancer in humans" is a misrepresentation of
the scientific facts.
With regard to trichloroethylene, Huff
admits that it does not induce the a2u-glob-
ulin-associated nephropathy; therefore, this
example is irrelevant and a misrepresentation
of facts. Huff tries to back his statement by
adding that a chemically similar compound
(perchloroethylene), which appears to be
linked (no proven causality) with human
renal cancer, was demonstrated to induce
a2u-globulin nephropathy and renal tumors
in male rats. To substantiate this statement,
he quotes Melnick (10), a paper that does
not provide new data but selectively quotes
Green et al. on perchloroethylene (33).
Green et al. (33) clearly state that the tumors
observed in the male rat kidney appear to be
related to a combination of at least two
mechanisms: genotoxicity from the f-lyase
pathway and the x2u-globulin mechanism.
However, Green et al. (33) also found that
even the genotoxic mechanism is also species
and sex specific and is of little relevance to
humans. Such synergy between a genotoxic
agent (initiator) and a promoting influence
(in this case the a2u-globulin mechanism via
enhanced cell proliferation) is well estab-
lished not only in renal carcinogenesis. That
is exactlywhy the EPA, in its ruling, restrict-
ed the relevance ofthe x2u-globulin mecha-
nism in conjunction with renal tumors
occurring only in male rats to nongenotoxic
chemicals. This emphasizes that we cannot
define a compound as either being an a2u-
globulin nephropathy inducer or not; we
have to understand the etiology of the
tumors induced by a given chemical to detect
whether only one or several mechanisms are
involved in its genesis.
Thus, neither the epidemiological stud-
ies on leaded gasoline nor any of the poly-
chlorinated aliphatics cited by Huff lend
themselves to questioning the a2u-globulin
mechanism. The available human epidemi-
ological studies and the animal experimen-
tal studies were misinterpreted and misrep-
resented by Huff. This distorts the factual
content ofthe data presented and the rami-
fications ofthese facts for human health.
Some ofthe other chemicals Huffmen-
tioned as being examples that contest the
a2u-globulin mechanism were gabapentin,
lindane, decalin, trimethylpentane (unlead-
ed gasoline), dimethyl methylphosphonate,
t-butyl alcohol, aud hexachlorobenzene. I
will not discuss all of the chemicals in
detail, although none ofthem are examples
that would contest the a2u-globulin medi-
ated mechanism. Instead, I would like to
point out some important facts that Huff
overlooked. The five examples selected for
discussion are representative.
As pointed out by Huff, gabapentin
induces an accumulation ofoa2u-globulin in
the proximal tubule epithelial cells of male
rats and, after prolonged administration (up
to 2, 7, and 14 days) and application of
2,000 mg/kg body weight (bw), even pro-
duces some cell necrosis and cell shedding
(34). No increase in renal cancer was
observed after 2 years ofgabapentin adminis-
tration (34). However, what Huff did not
find necessary to point out is that, in all cases
where chemicals induced oa2u-globulin
nephropathy and renal tumors, increased
amounts ofproteinaceous intratubular casts,
especially at the cortico-medullary junction,
and, consequently, increased cell regeneration
were observed (20,21,35,36). Indeed, chron-
ic increased cell regeneration is the hallmark
of chemically induced renal tumors via the
a2u-globulin mechanism (1). The question
then arises whether the prolonged gabapentin
administration induced increased numbers of
proteinaceous intratubular casts, especially at
the cortico-medullary junction, and conse-
quendyenhanced rates ofcell regeneration. A
closerlook at the paper ofDominick et al. on
gabapentin (34) clearly indicates that no
dose response was observed in the number of
casts or in the severity ofrenal tubular regen-
eration at 13 weeks ofexposure (doses up to
3,000 mg/kg bw). This data clearly indicates
that the severity of ax2u-globulin accumula-
tion and subsequent cell necrosis and prolif-
erative regeneration was not high enough to
allow for formation of renal tumors within
the 2 years of gabapentin exposure.
Dominick et al. (34) also found foci ofatypi-
cal hyperplasia in kidneys ofmale rats treated
with 1,000 and 2,000 mg/kg bw at termina-
tion of the 2-year bioassay. Atypical tubules
and atypical hyperplasia have been recog-
nized as precursors ofrenal adenoma and car-
cinoma (19-21,32). The reported number of
atypical foci was extremely low in the
Dominick et al. study (34). In summary, the
present database on gabapentin does not dis-
prove the a2u-globulin-associated mecha-
nism of renal carcinogenesis, but rather
demonstrates that chemicals that cause a2u-
globulin-mediated renal cancer must bind to
a2u-globulin with high affinity to produce
chronic elevated cell necrosis and subsequent
cell regeneration. Indeed, this view is also
shared by Dominick et al. (34) who specifi-
callystated in their paper that
this study suggests that proximal tubular
epithelial injury and regeneration that occur
in this [a2u-globulin] nephropathy may need
to reach a critical threshold to effectively pro-
mote renal neoplasia.
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The second compound that Huff men-
tioned as being one of the compounds that
does not induce renal tumors in male rats
despite being a typical a2u-globulin com-
pound is lindane. It is indeed true that lin-
dane and its metabolites can bind to ax2u-
globulin and induce the associated
nephropathy in male rats during acute expo-
sures (37). Lindane (and/or its metabolites)
has been shown in the 2-year carcinogenicity
bioassay to increase the incidence ofbenign
and malignant neoplasms in endocrine
organs (pituitary, adrenal, and thyroid) of
both sexes; however, a high incidence of
ovarian carcinoma was also noted (38).
Moreover, male rats treated with lindane at
32 and 64 mg/kg bw for 2 years presented
with severe testicular atrophy. It is thus quite
reasonable to assume that the testosterone
level in these rats, as a consequence oftestic-
ular atrophy, was low. However, testosterone
is extremely important for maintaining a
high level ofliver-derived a2u-globulin, as
will be outlined below. Indeed the male rat
major urinary protein (the hepatic form of
x2u-globulin) is encoded by a family of
25-30 copies of highly homologous (less
than 5% divergence in the nucleic acid
sequence) genes within the haploid genome,
each made up of 7 exons and clustered on
chromosome 5 (39,40). The expression of
this ax2u-globulin gene familyis regulated by
a complex interaction oftestosterone, gluco-
corticoids, insulin, growth hormone, and
thyroid hormone (4). The synthesis of
hepatic a2u-globulin is under androgenic
control, as evidenced by changes in andro-
gen sensitivity and androgenic induction of
a2u-globulin synthesis, which begins at
puberty (approximately 40 days in rats),
peaks at about 80 days, and then steadily
dedines in expression level only to cease at
senescence (i.e., 750-800 days ofage) (41).
The maturational rise in a2u-globulin syn-
thesis and its dedine during senescence are
associatedwith corresponding changes in the
expression ofthe androgen receptor gene in
the liver and thus with changes in the
steady-state level of the a2u-globulin
mRNA (42). Transcriptional activation of
the a2u-globulin gene coincides with its
attachment to the nuclear matrix, while con-
versely, senescent-associated transcriptional
inactivation is accompanied by matrix
detachment ofthis gene (40).
Estrogenic steroids are very effective
repressors of a2u-globulin synthesis (43).
Indeed, estrogen receptor complexes were
shown to bind to the promoter region of
the a2u-globulin genes (44) and were thus
able to repress the expression ofthese genes.
It is thus not surprising that female rats,
with their inherently high levels ofestrogen,
do not synthesize hepatic a2u-globulin or
its corresponding mRNA, despite having
the entire complement ofhepatic a2u-glob-
ulin genes (16,45,46). Ovariectomized
female rats have a very lowbackground level
ofa2u-globulin mRNA (47), and ovariec-
tomy in conjunction with androgen treat-
ment offemale rats results in an increase of
a2u-globulin mRNA as well as protein
product (45,48).
Male rats after puberty, on the other
hand, were shown to have high levels of
estrogen sulfotransferase, an enzyme able to
inactivate estrogen activity and thus main-
tain androgen sensitivity of the male rat
liver during the peak phase of(x2u-globulin
synthesis (491.
Based on the assumption that high lev-
els of a2u-globulin could not have been
maintained in male rats treated with high
doses oflindane in the 2-year bioassay, due
to testicular atrophy and thus a lack of
testosterone, it becomes obvious why renal
tumors did not develop in lindane-treated
male rats. Lindane, therefore, is not a com-
pound that would question the a2u-globu-
lin-mediated mechanism of male rat renal
tumors as Huffbelieves, but rather it sup-
ports the mechanism.
The question that remains is why lin-
dane was reported to induce x2u-globulin
nephropathy. Indeed, a2u-globulin
nephropathy was observed in male rats
treated with lindane 10 mg/kg bw day for
5 days (37). The levels of cx2u-globulin
and the resistance to lysosomal breakdown
of the a2u-globulin-lindane complex was
high enough that this nephropathy could
be observed under acute exposure. In con-
trast, no hyaline droplets, nephropathy, or
renal casts were observed in the rats dosed
with 32 and 64 mg/kg bw for 2 years in
the cancer bioassay (38).
With regard to risk assessment, lindane
could have not been regulated under EPA's
ruling on x2u-globulin nephropathy-
inducing compounds, based on the fact
that no renal tumors were detected in male
rats and that tumors in other organs in
both male and female rats were induced in
the 2-year bioassay. Lindane, however,
may well be an example of the problems
associated with the maximum-tolerated-
dose (MTD) approach in the 2-year cancer
bioassays. It is indeed conceivable that
male rats would have developed renal
tumors in the 2-year bioassay ifthe chronic
dose had been at a concentration that
would not have induced testicular atrophy
and thus not have impeded testosterone
production. In conclusion, lindane does
not provide a good example to substantiate
theories, but rather it exemplifies how a
lack of understanding of mechanisms can
lead to misconceptions.
The latter statement also holds true for
decalin. Indeed, Huffstates that
decalin is probably the first chemical for
which no empirical connection could be
made between induced hyaline droplet-
[ca2u-globulin] nephropathy syndrome and
cancer ofthe renal epithelial cells.
Huff cites Gaworski et al. (50), who
quite clearly demonstrate all classical symp-
toms of an a2u-globulin-mediated mecha-
nism; this 90-daystudy could not have pro-
moted the necessary number ofpreneoplas-
tic lesions that would have progressed to
veritable tumors within the 19-month post-
exposure observation period. Indeed, the
a2u-globulin-mediated mechanism ofrenal
tumor induction is a pure promotional
process. Thus, a chronic stimulus (chronic
cell necrosis and subsequent chronic cell
regeneration) is necessary for a low induced
incidence ofrenal tumors to be observed at
the end of a 2-year bioassay. Furthermore,
the promotional effect ofthe a2u-globulin
mechanism is weak, leading to low renal
tumor incidences in 2-year rat bioassays (up
to 25%) (51), while other presumably
nongenotoxic compounds, e.g., ochratoxin
A, lead to high renal tumor incidences (up
to 87%) in both sexes of rats (52).
Therefore, Huffs statement that
at the end ofthe post-exposure period, male
rats exhibited dose-related chronic progres-
sive necrosis with accentuated tubular
degeneration, medullary mineralization, and
papillary hyperplasia; however, no tumor of
the kidney was reported for male rats or for
anyother sex-species-exposure group
is incorrect. Indeed, mentioning chronic
progressive necrosis and tubular degenera-
tion in conjunction with decalin treatment
is misleading in this context. These symp-
toms are characteristic for aging rats (53),
but can be exaggerated in a dose-related
fashion following exposure to chemicals
(19). However, there is no distinct associa-
tion or causality between the occurrence
lesions ofchronic progressive necrosis (also
known as chronic progressive nephropathy)
and the etiology ofa2u-globulin-chemical
complex-mediated renal tumors. Therefore,
insinuating that in the case of decalin,
despite the presence ofchronic progressive
necrosis, no tumors related to a2u-globu-
lin were observed is a misconception that
unnecessarily leads to misunderstandings.
Unfortunately no 2-year cancer bioassay
has been conducted to date on decalin. It is
hoped that, as Huffpointed out, the NTP
will conduct a 2-year bioassay with decalin
using F344 and the a2u-globulin-deficient
NBR rats in the near future. I am quite
confident that this study, as many others
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before, will substantiate the currently
accepted mechanism.
The two last compounds that are worth
discussing are trimethylpentane and hexa-
chlorobenzene. Trimethylpentane (TMP)
was demonstrated to bind to a2u-globulin
(54-57) and to induce a2u-globulin
nephropathy in male rats (36,58).
Prolonged treatment ofmale rats with TMP
exacerbates the nephropathy and increases
regenerative cell proliferation in a dose-
dependent manner (36,59,60). NBR rats
lacking x2u-globulin do not produce pro-
tein accumulation or nephropathy following
treatment with TMP (22). TMP was also
demonstrated to be a renal tumor promoter
(via the x2u-globulin-mediated mecha-
nism) in a classic initiation-promotion
study by Short et al. (19). This fact stands
out against Huffs statement that TMP had
been demonstrated not to induce renal
tumors in a 2-year study. The literature
cited, which back the cx2u-globulin-mediat-
ed mechanism, appeared in peer-reviewed
journals and thus were open for scientific
scrutiny. On the contrary, Huffs statement
is backed bya personal communication on a
bioassay of which the experimental condi-
tions and the actual resulting data are not
available; these studies by the Instituto
Ramazzini have not been duplicated by
another laboratory using a different strain of
rats, whereas the studies supporting the
a2u-globulin-mediated mechanism have
been reproduced in various laboratories. In
this, Huff does not seem to be carefully
weighing the evidence.
Hexachlorobenzene (HCB) was shown
to induce x2u-globulin nephropathy in
male rats but not in female rats, even when
treated for 50 days at the highest dose (61).
The statement by Huff that "hexa-
chlorobenzene (HCB) is an example of a
chemical that induces the [o2u-globulin]
nephropathy syndrome in male and female
Sprague-Dawley rats..." (61) is a misrepre-
sentation of facts. Female rats do not pre-
sent with the x2u-globulin nephropathy
syndrome in any case so far discussed.
Furthermore, female rats did not present
with any form ofrenal pathology, ofwhat-
ever etiology, in the 50-day study by
Bouthillier (61). It is true, however, that
both sexes of rats treated with HCB pre-
sented with hepatomas (male, 11/56;
female, 35/56), hepatocellular carcinomas
(male, 4/56; female, 48/56), bile duct ade-
nomas (male, 2/56; female, 29/56), and
renal adenomas (male, 42/56; female,
15/56) (62. The incidences ofrenal adeno-
mas were decisively higher in male than in
female rats. The overt increase in liver carci-
nomas and bile duct tumors in both sexes of
Sprague Dawley rats indicates that several
mechanisms are involved in the etiology of
liver, bile duct, and renal tumors, one of
them most likely being a genotoxic mecha-
nism. Hexachlorobenzene, therefore, is not
an example that would contest the oc2u-
globulin hypothesis. Huffstates that "HCB
is the first chemical identified that exhibits
the [ca2u-globulin] nephropathy sequelae,
and induces renal cell tumors in both gen-
ders ofrats." This statement is a misconcep-
tion and misrepresentation of facts. In this
context, it is also wrong and misleading of
Huff to insinuate that HCB would have
been regulated under the EPA ruling dis-
cussed here. Indeed, the EPA ruling on
a2u-globulin-inducing compounds clearly
concerns compounds only that 1) are
nongenotoxic; 2) produce renal tumors in
male rats and in no other sex, species, or
organ; and 3) induce the ox2u-globulin
nephropathy syndrome. Hexachlorobenzene
does not fulfill two of the above categories
and should therefore not be given as an
example in this context.
In conclusion, I would like to empha-
size that one needs at least as excellent a
database to disprove a currently accepted
mechanism as was used to establish the
mechanism in the first place. Questioning
for queries sake is not helpful, but is rather
hindersome to those scientists that excel in
distinguishing those mechanisms that are
relevant to humans and can be predicted
via animal experimentation from those that
are specific to the surrogate animals only.
In his letter in Environmental Health
Perspectives, James Huff was clearly not
able to disprove the currently accepted
mechanism; I challenge him to produce
some experimental data to substantiate his
hypothesis.
Daniel R. Dietrich
University ofKonstanz
Environmental Toxicology Laboratory
Konstanz, Germany
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The Relevance of Mechanistic
Data to the Interpretation and
Extrapolation to Humans of
Rodent Carcinogenicity Data
I refer to Huffs response (1) to my letter to
EHP regarding the adequacy of the a2u-
globulin nephropathy mechanism of tumor
induction in male rats (2) and to the reponse
by Dietrich (3) to the points made by Huff
(1). Pursuit of the mechanisms by which
chemicals are toxic to mammals can bejusti-
fied in two ways. The first is that the acquisi-
tion of such knowledge may increase our
ability to prevent or attenuate human dis-
eases. The second is that mechanistic data
can contribute significantly to our ability to
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